While cancers such as breast, lung, and prostate frequently dominate public health discussions, there is a far less recognised but equally aggressive form - sarcoma. It affects thousands across the UK ...
VCU Massey is the first U.S. site in a global phase 2a trial for PTX-100, targeting cutaneous T-cell lymphoma. The BIPAVE-001 trial is evaluating AI-081, a PD-1 and VEGF bispecific antibody, for ...
Oncology advancements focus on precision medicine, liquid biopsies, and novel therapies to improve outcomes and address care disparities. Value-based care models prioritize patient-centered approaches ...
Highlighting the urgent need for awareness and support for sarcoma, a rarely discussed but serious cancer affecting many.
GlobalData on MSN
MSD begins KANDLELIT-007 trial of calderasib for NSCLC
Newly diagnosed patients with KRAS G12C-mutant advanced or metastatic nonsquamous NSCLC will be enrolled in the trial.
Moleculin Biotech, Inc. announced promising results from their Phase 1B/2 trial of Annamycin for treating soft tissue sarcoma lung metastases, showing a robust clinical benefit rate of 59.4% among ...
I am a two-time cancer survivor. In 2016, I was diagnosed with synovial sarcoma and completed my treatment in 2017. Later, in ...
Shame can shape how early patients get diagnosed, and how aggressively they pursue treatment, if at all. In a 2014 study, Dr.
With the rising burden of cancer in India, awareness around common cancers such as breast, lung and oral cancer has increased ...
Squamous cell carcinoma of the lung is linked to smoking and requires early detection and accurate staging for effective treatment. Diagnosis involves imaging and biopsy, with the TNM system used to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results